Investor Relations

Investor Overview

KemPharm uses its LAT platform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.


Stock Quote
KMPH (Common Stock)
PriceChange% ChangeVolume
$4.60 - 0.234.76%124,730
Previous CloseToday's OpenIntraday HighIntraday Low
Exchange: NASDAQ (US Dollar)
08/26/16 4:00 p.m. ET
Refresh quote
Recent NewsMore >>
KemPharm, Inc. Reports Second Quarter 2016 Results
KemPharm, Inc. to Report Second Quarter 2016 Results
KemPharm to Present at Canaccord Genuity 36th Annual Growth Conference
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources